Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
27.20
-0.45 (-1.63%)
At close: Mar 18, 2026, 4:00 PM EDT
27.35
+0.15 (0.55%)
Pre-market: Mar 19, 2026, 4:28 AM EDT
Alkermes Employees
Alkermes had 2,050 employees as of December 31, 2025. The number of employees increased by 250 or 13.89% compared to the previous year.
Employees
2,050
Change (1Y)
250
Growth (1Y)
13.89%
Revenue / Employee
$719,951
Profits / Employee
$117,885
Market Cap
4.53B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,050 | 250 | 13.89% |
| Dec 31, 2024 | 1,800 | -300 | -14.29% |
| Dec 31, 2023 | 2,100 | -180 | -7.89% |
| Dec 31, 2022 | 2,280 | 69 | 3.12% |
| Dec 31, 2021 | 2,211 | -34 | -1.51% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Amneal Pharmaceuticals | 8,700 |
| Phibro Animal Health | 2,475 |
| Hims & Hers Health | 2,442 |
| HUTCHMED (China) | 1,796 |
| Lantheus Holdings | 1,193 |
| Supernus Pharmaceuticals | 778 |
| Prestige Consumer Healthcare | 600 |
ALKS News
- 6 days ago - Alkermes Announces Inaugural Alkermes Pathways APN Research Awards™ Program - Business Wire
- 8 days ago - Alkermes to Present at the Stifel 2026 Virtual CNS Forum - Business Wire
- 21 days ago - Alkermes plc (ALKS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2025 and Provides Financial Expectations for 2026 - Business Wire
- 21 days ago - Alkermes plc Announces CEO Succession Plan - Business Wire
- 22 days ago - Alkermes to Present at the TD Cowen 46th Annual Health Care Conference - Business Wire
- 4 weeks ago - Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market - Business Wire
- 5 weeks ago - Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026 - Business Wire